Here's the recent articles submitted by vasista pharma
Articles By vasista pharma
Resmetirom: A New Approach To Treating Fatty Liver Disease
Submitted as: vasista Group
Resmetirom is a new prescriptive drug. It is used primarily to cure a severe liver disease known as NASH only in adults. NASH is an abbreviation that is used to refer to Non-Alcoholic Steato Hepatitis. It is a subset of a larger complication commonly referred to as fatty liver disease. In NASH, the liver of a person gets filled with fat and this fat irritates and damages. In the long run, this may result in scarring (also known as fibrosis), cirrhosis (severe scarring), liver failure or liver cancer.(read
entire article)
View : 39 Times
Category : Business
Cinacalcet: A Comprehensive Guide To Uses, Interactions, And Mechanism Of Action
Submitted as: vasista Group
Cinacalcet is a prescription drug that is primarily used to balance unrealistically high parathyroid hormone (PTH), calcium, and phosphorus levels in the body. It is called a calcimimetic and that is, it imitates calcium in the body and aids in PTH features. Cinacalcet is also prescribed to individuals with chronic kidney disease or some parathyroid issues.(read
entire article)
View : 25 Times
Category : Business
Finerenone: Uses, Interactions, And Mechanism Of Action
Submitted as: vasista Group
Finerenone is a new type of medicine used to treat kidney and heart problems, especially in people with chronic kidney disease (CKD) linked to type 2 diabetes. It is a non-steroidal mineralocorticoid receptor blocker (MRA), which is a type of drug. While older medicines in this group, such as spironolactone and eplerenone, have been used for years, finerenone works in a more selective way and may cause fewer side effects.(read
entire article)
View : 31 Times
Category : Business
Cas No: 3536-96-7 Manufacturers – Market Overview And Industry Insights
Submitted as: vasista Group
Vasista Group has established itself as a prominent and influential player in the highly competitive pharmaceuticals manufacturing industry. As the demand for the unique chemical compound Cas No: 3536-96-7 continues to soar, the need for trustworthy and reliable manufacturers becomes paramount. In this regard, Vasista Group has emerged as a leading Cas No: 3536-96-7 manufacturer, boasting an impressive track record of excellence in producing high-quality chemicals catering to pharmaceutical, research, and industrial purposes.(read
entire article)
View : 11 Times
Category : Business
3-butyn-1-ol Manufacturers: Industry Overview, Production Insights, And Market Trends
Submitted as: vasista Group
It is an intermediate for Pemetrexed. 3-Butyn-1-ol is a terminal acetylenic compound that is but-1-yne with one of the methyl hydrogens substituted by a hydroxy group. It is a member of butyn-1-ols and a terminal acetylenic compound.
Pemetrexed is a chemotherapy drug and is indicated for use in combination with cisplatin for the treatment of patients with malignant pleural mesothelioma whose disease is either unresectable or who are otherwise not candidates for curative surgery. Its use in non-small cell lung cancer has also been investigated.(read
entire article)
View : 6 Times
Category : Business
Understanding 2,2,6,6-tetramethylpiperidinyl Magnesium Chloride Lithium Chloride Complex Manufacturers
Submitted as: vasista Group
Vasista Life Sciences has become a major and important participant in the competitive field of medicines manufacturing. As the demand for rare chemical substances CAS No: 898838-07-8 keeps going up, it is more important than ever to find trustworthy and dependable manufacturers. In this sense, Vasista Life Sciences has become one of the best CAS No: 898838-07-8 manufacturers, with a long history of making high-quality chemicals for use in pharmaceuticals, research, and industry.(read
entire article)
View : 2 Times
Category : Business
